Category:
Cardiovascular System Drugs
CAS NO:
738606-46-7
Standard:
In-house Standards,
Bempedoic Acid, also known as ETC-1002 or by its trade name NEXLETOL™, is an oral ATP-citrate lyase (ACL) inhibitor. It was first approved by the U.S. FDA in 2020 for marketing as an adjunct to diet and maximally tolerated statin therapy to reduce low-density lipoprotein cholesterol (LDL-C) levels in adults with heterozygous familial hypercholesterolemia (HeFH) or clinically significant atherosclerotic cardiovascular disease (ASCVD).